Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-111156
Filing Date
2020-10-01
Accepted
2020-10-01 17:15:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2031213d1_424b5.htm 424B5 303642
2 GRAPHIC image_001.jpg GRAPHIC 30807
3 GRAPHIC image_002.jpg GRAPHIC 11396
  Complete submission text file 0001104659-20-111156.txt   363250
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230604 | Film No.: 201217067
SIC: 2836 Biological Products, (No Diagnostic Substances)